![]()
CVRX Shareholder Alert: CVRx, Inc. Securities Class Action Lawsuit – Investors With Losses May Contact Levi & Korsinsky
PR Newswire
NEW YORK, Nov. 18, 2026
CVRx shareholders absorbed a $3.55 per-share, 60% single-session loss after one after-hours filing disclosed a federal False Claims Act probe into alleged Barostim kickbacks, together with a guidance cut tied to weak sales force productivity.
NEW YORK, Nov. 18, 2026 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in CVRx, Inc. (Nasdaq: CVRX) that a class action lawsuit has been filed on behalf of shareholders who purchased securities between July 25, 2023 and August 6, 2026. Find out if you may qualify to recover losses. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.
CVRX closed at $5.94 on August 6, 2026 and at $2.39 on August 7, 2026, a loss of $3.55 per share, or 60%, in one session on heavy volume. To be considered for lead plaintiff, investors must file by January 8, 2027.
One After-Hours Filing, Two Alleged Shocks
The selloff followed a single Form 10-Q that CVRx filed after the market closed on August 6, 2026. In that filing, the Company disclosed that on May 14, 2026 it had received a civil investigative demand from the U.S. Department of Justice under the False Claims Act. The demand sought information on whether CVRx caused false claims to government health insurance programs by improperly marketing Barostim, offering or paying kickbacks to healthcare providers, or providing false information to those programs.
The same day, CVRx lowered its outlook and cited weak productivity in a sales force made up largely of recent hires. The complaint charges that these disclosures corrected statements made throughout the Class Period about the sustainability of Barostim revenue and the progress of the Company’s sales force realignment.
The August 7 Selloff by the Numbers
- Pre-disclosure close: $5.94 per share on August 6, 2026
- Post-disclosure close: $2.39 per share on August 7, 2026
- Single-session decline: $3.55 per share, or 60%, on heavy volume
- Disclosure gap: the Company reports receiving the DOJ demand on May 14, 2026, and shareholders first learned of it in the August 6 filing, roughly 12 weeks later
- Trading window covered: more than three years of purchases, from July 25, 2023 through August 6, 2026
Why Shareholders Allege CVRX Traded Too High
As averred, investors who bought during the Class Period paid prices that did not reflect the risk that Barostim sales were partly the product of alleged unlawful marketing and kickback practices. The prices also did not reflect the alleged reality that the commercial team required further training and restructuring to achieve expected productivity levels. The pleading asserts that when both risks reached the market in one filing, the resulting decline caused significant losses for class members.
“CVRX shareholders watched the stock lose 60% of its value in a single session once a federal False Claims Act inquiry and a guidance cut surfaced in the same filing. The complaint raises serious questions about whether the prices investors paid between July 2023 and August 2026 reflected risks that the lawsuit contends were already present inside the Company.” — Joseph E. Levi, Esq.
Submit your information here or call (212) 363-7500.
ABOUT THE FIRM — For over two decades, Levi & Korsinsky has represented shareholders in securities class actions. Ranked in ISS Top 50 for seven consecutive years. Investors who suffered losses have until January 8, 2027 to seek appointment as lead plaintiff.
Frequently Asked Questions About the CVRX Lawsuit
Q: Who are the defendants named in the CVRX lawsuit? A: The complaint names CVRx, Inc. and individual defendants including senior executives who signed SEC filings, made public statements, or certified financial disclosures under Sarbanes-Oxley.
Q: What is the CVRX class action lawsuit about? A: A securities class action has been filed against CVRx, Inc. (Nasdaq: CVRX) alleging materially false and misleading statements between July 25, 2023 and August 6, 2026. Shares fell approximately 60% after the Company disclosed a U.S. Department of Justice civil investigative demand under the False Claims Act and lowered its guidance, citing weak sales force productivity. Investors who purchased shares during the Class Period and suffered losses may be eligible to seek compensation.
Q: Who is eligible to join the CVRX investor lawsuit? A: Investors who purchased CVRX stock or securities between July 25, 2023 and August 6, 2026 and suffered financial losses may be eligible. Eligibility is based on purchase date and documented losses — not on whether you still hold the shares.
Q: What is a lead plaintiff and why does it matter? A: A lead plaintiff is the investor appointed by the court to represent the entire class. Lead plaintiffs are typically investors with the largest documented losses. Being appointed does not increase individual recovery but gives direct oversight of how the case is run.
Q: What happens after I provide my information? A: Your trading history will be reviewed at no cost for an initial assessment of your potential eligibility.
Q: What if I already sold my CVRX shares — can I still recover losses? A: Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought during the Class Period and sold at a loss may still be eligible to participate.
Q: Do I need to go to court or give testimony? A: No. The overwhelming majority of class members never appear in court or give depositions. If there is a settlement or recovery, eligible class members generally submit a claim form to seek their portion.
Q: Can I join a different law firm’s lawsuit instead? A: Yes. Investors may choose which law firm to contact. Multiple firms often file competing complaints. The court may consolidate related cases and appoint a single lead counsel.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
Tel: (212) 363-7500
Fax: (212) 363-7171
Attorney Advertising. Prior results do not guarantee similar outcomes.
View original content to download multimedia:https://www.prnewswire.com/news-releases/cvrx-shareholder-alert-cvrx-inc-securities-class-action-lawsuit—investors-with-losses-may-contact-levi–korsinsky-302943462.html
SOURCE Levi & Korsinsky, LLP
